The Wrexham Maelor Hospital is a district general hospital for the north east region of Wales. It is managed by Betsi Cadwaladr University Health Board.

There are 800 beds in Wrexham Maelor Hospital.

During the past decade, Wrexham Maelor Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wrexham Maelor Hospital" #1 sponsor was "Lisette Nixon" with 4 trials, followed by "University of Edinburgh" with 3 trials sponsored, "University College, London" with 2 trials sponsored, "Wales Cancer Trials Unit" with 2 trials sponsored and "Allena Pharmaceuticals" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wrexham Maelor Hospital" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "NHS Lothian" with 2 trials as a collaborator, "Asociación Científica Pulmón y Ventilación Mecánica" with 1 trials as a collaborator and "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Wrexham Maelor Hospital" are "Breast Cancer" (3 trials), "Fallopian Tube Cancer" (3 trials), "Ovarian Cancer" (3 trials), "Colorectal Cancer" (2 trials) and "Oesophageal Cancer" (2 trials). Many other conditions were trialed in "Wrexham Maelor Hospital" in a lesser frequency.

Most popular intervention types in "Wrexham Maelor Hospital" are "Drug" (21 trials), "Biological" (5 trials), "Procedure" (5 trials), "Radiation" (5 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (5 trials), "Placebo" (3 trials), "Radiotherapy" (2 trials), "adjuvant therapy" (2 trials) and "cetuximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wrexham Maelor Hospital" are 27 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Wrexham Maelor Hospital". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Wrexham Maelor Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wrexham Maelor Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".